Decreased hyperlocomotion induced by MK-801, but not amphetamine and caffeine in mice lacking cellular prion protein (PrP(C)).

The cellular prion protein (PrP(C)) has been involved in several neurodegenerative disorders however it has been proposed that it is also be implicated in psychotic disorders. We investigated the effect of three psychotropic drugs in locomotor activity of PrP(C) knockout (Prnp(O/O)) and wild-type mice. The NMDA receptor channel blocker MK-801 (0.25 mg/kg), the indirect dopamine agonist amphetamine (1 mg/kg) and the adenosine receptor antagonist caffeine (10 mg/kg) were administered i.p. after 60 min of habituation and locomotion was monitored for 3 h. Prnp(O/O) mice presented a diminished hyperlocomotor response to MK-801 treatment but normal response to amphetamine and caffeine compared to wild type mice. These results suggest that lack of PrP(C) leads to a functional alteration in the glutamatergic system, whereas the regulation of both dopaminergic and adenosinergic systems are preserved. Finally, lack of PrP(C) seems not to exacerbate the response to these psychotropic drugs, which modulate neurotransmitter systems possibly involved in schizophrenia and psychotic disorders.

[1]  I. Izquierdo,et al.  Normal inhibitory avoidance learning and anxiety, but increased locomotor activity in mice devoid of PrP(C). , 1999, Brain research. Molecular brain research.

[2]  A. F. Mercadante,et al.  Insights into the physiological function of cellular prion protein. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[3]  D. Souza,et al.  Schizophrenia: a purinergic hypothesis. , 2000, Medical hypotheses.

[4]  R. Brentani,et al.  Complementary hydropathy identifies a cellular prion protein receptor , 1997, Nature Medicine.

[5]  H. Ushijima,et al.  Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. , 1993, European journal of pharmacology.

[6]  J. Newcomer,et al.  NMDA receptor hypofunction model of schizophrenia. , 1999, Journal of psychiatric research.

[7]  D. Rujescu,et al.  Methionine Homozygosity at Codon 129 in the Prion Protein Is Associated with White Matter Reduction and Enlargement of CSF Compartments in Healthy Volunteers and Schizophrenic Patients , 2002, NeuroImage.

[8]  J. Kourie.  Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity. , 2001, Chemico-biological interactions.

[9]  B. Caughey,et al.  Prion protein interconversions and the transmissible spongiform encephalopathies. , 1999, Structure.

[10]  A. Aguzzi,et al.  Mice devoid of PrP are resistant to scrapie , 1993, Cell.

[11]  Inyoul Y. Lee,et al.  Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. , 1999, Journal of molecular biology.

[12]  C. Weissmann,et al.  Molecular Genetics of Transmissible Spongiform Encephalopathies* , 1999, The Journal of Biological Chemistry.

[13]  L. Iversen,et al.  The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Aguzzi,et al.  Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain , 2001, The EMBO journal.

[15]  S. Prusiner,et al.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein , 1992, Nature.

[16]  I. Izquierdo,et al.  Cellular prion protein binds laminin and mediates neuritogenesis. , 2000, Brain research. Molecular brain research.

[17]  David R. Brown.  Copper and prion disease , 2001, Brain Research Bulletin.

[18]  J. Sturman,et al.  Altered GABA distribution in hamster brain is an early molecular consequence of infection by scrapie prions , 1995, Brain Research.

[19]  R. Linden,et al.  Cellular prion protein transduces neuroprotective signals , 2002, The EMBO journal.

[20]  S. Ratté,et al.  Post‐natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration , 2002, The EMBO journal.

[21]  A. Nieoullon,et al.  Changes in tyrosine hydroxylase, glutamic acid decar☐ylase and choline acetyltransferase after local microinoculation of scrapie agent into the nigrostriatal system of the golden hamster , 1985, Brain Research.

[22]  T. Noda,et al.  Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene , 1996, Nature.

[23]  R. Brentani,et al.  Laminin‐induced PC‐12 cell differentiation is inhibited following laser inactivation of cellular prion protein , 2000, FEBS letters.

[24]  R. Brentani,et al.  Can loss-of-function prion-related diseases exist? , 1998, Molecular Psychiatry.

[25]  A. Simpson,et al.  A prion-linked psychiatric disorder , 1997, Nature.

[26]  O. Amaral,et al.  Increased Sensitivity to Seizures in Mice Lacking Cellular Prion Protein , 1999, Epilepsia.

[27]  M. Rogawski,et al.  Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice , 1995, Behavioural Brain Research.

[28]  M. Palmer,et al.  Prion protein is necessary for normal synaptic function , 1994, Nature.

[29]  T. Hökfelt,et al.  Decreased MK-801 Binding in Discrete Hippocampal Regions of Prion-Infected Mice , 2001, Neurobiology of Disease.

[30]  David R. Brown.  Prion and prejudice: normal protein and the synapse , 2001, Trends in Neurosciences.

[31]  I. Izquierdo,et al.  Cellular prion protein: on the road for functions , 2002, FEBS letters.

[32]  C.-H. Chen,et al.  Lack of evidence to support the association of the human prion gene with schizophrenia , 2001, Molecular Psychiatry.

[33]  M. Laruelle,et al.  Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies , 1999, Journal of psychopharmacology.